Advertisement

Cancer and IgE pp 137-158 | Cite as

Mast Cells in Allergy and Tumor Disease

  • Anna Wasiuk
  • Victor C. de Vries
  • Elizabeth C. Nowak
  • Randolph J. NoelleEmail author
Chapter

Abstract

In allergy, mast cells (MCs) are known for the notoriously detrimental role they play. MC mediators like histamine, prostaglandins, leukotrienes and thromboxane are released during the early phase of an allergic reaction and produce inflammation and local tissue responses. One pervasive roadblock in the effective development of therapeutic immunity to cancer is the fact that tumors create immune privileged sites that are resistant to the development of effective inflammation and effective anti-tumor responses. In this chapter we will present the current knowledge of the inflammatory responses elicited in allergies by IgE and MCs as well as the current knowledge on how the responses of MCs may regulate tumor growth and the immune response to tumors.

Keywords

Vascular Endothelial Growth Factor Mast Cell Atopic Dermatitis Helminth Infection Airway Smooth Muscle Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Krishnaswamy G. (2005) Mast Cells: Methods and Protocols. Humana Press, New York.Google Scholar
  2. 2.
    Yazdanbakhsh, M., A. van den Biggelaar, and R. M. Maizels. (2001) Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 22:372–377.PubMedGoogle Scholar
  3. 3.
    Lynch, N. R., R. I. Lopez, M. C. Di Prisco-Fuenmayor, I. Hagel, L. Medouze, G. Viana, C. Ortega, and G. Prato. (1987) Allergic reactivity and socio-economic level in a tropical environment. Clin Allergy 17:199–207.PubMedGoogle Scholar
  4. 4.
    Masters, S., and E. Barrett-Connor. (1985) Parasites and asthma – predictive or protective? Epidemiol Rev 7:49–58.PubMedGoogle Scholar
  5. 5.
    Scrivener, S., H. Yemaneberhan, M. Zebenigus, D. Tilahun, S. Girma, S. Ali, P. McElroy, A. Custovic, A. Woodcock, D. Pritchard, A. Venn, and J. Britton. (2001) Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 358:1493–1499.PubMedGoogle Scholar
  6. 6.
    Molomut, N., D. M. Spain, L. Kreisler, and L. J. Warshaw. (1955) The effect of an allergic inflammatory response in the tumor bed on the fate of transplanted tumors in mice. Cancer Res 15:181–183.PubMedGoogle Scholar
  7. 7.
    Augustin, R., S. O’Sullivan, and I. Davies. (1971) Isolation of grass pollen antigens failing to induce IgE reagin formation although capable of inducing IgG antibody formation. Int Arch Allergy Appl Immunol 41:144–147.PubMedGoogle Scholar
  8. 8.
    Jacobs, D., J. Landon, M. Houri, and T. G. Merrett. (1972) Circulating levels of immunoglobulin E in patients with cancer. Lancet 2:1059–1061.PubMedGoogle Scholar
  9. 9.
    McCormick, D. P., A. J. Ammann, K. Ishizaka, D. G. Miller, and R. Hong. (1971) A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia. Cancer 27:93–99.PubMedGoogle Scholar
  10. 10.
    Ure, D. M. (1969) Negative association between allergy and cancer. Scott Med J 14:51–54.PubMedGoogle Scholar
  11. 11.
    Pereira, E. A., D. A. Silva, J. P. Cunha-Junior, K. C. Almeida, R. Alves, S. J. Sung, and E. A. Taketomi. (2005) IgE, IgG1, and IgG4 antibody responses to Blomia tropicalis in atopic patients. Allergy 60:401–406.PubMedGoogle Scholar
  12. 12.
    Maurer, M., T. Theoharides, R. D. Granstein, S. C. Bischoff, J. Bienenstock, B. Henz, P. Kovanen, A. M. Piliponsky, N. Kambe, H. Vliagoftis, F. Levi-Schaffer, M. Metz, Y. Miyachi, D. Befus, P. Forsythe, Y. Kitamura, and S. Galli. (2003) What is the physiological function of mast cells? Exp Dermatol 12:886–910.PubMedGoogle Scholar
  13. 13.
    Algermissen, B., B. Hermes, I. Feldmann-Boeddeker, F. Bauer, and B. M. Henz. (1999) Mast cell chymase and tryptase during tissue turnover: analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Exp Dermatol 8:193–198.PubMedGoogle Scholar
  14. 14.
    Kataoka, T. R., N. Komazawa, E. Morii, K. Oboki, and T. Nakano. (2005) Involvement of connective tissue-type mast cells in Th1 immune responses via Stat4 expression. Blood 105:1016–1020.PubMedGoogle Scholar
  15. 15.
    Kaplan, M. H., A. L. Wurster, and M. J. Grusby. (1998) A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J Exp Med. 188:1191–1196.PubMedGoogle Scholar
  16. 16.
    Yoshimoto, T., H. Tsutsui, K. Tominaga, K. Hoshino, H. Okamura, S. Akira, W. E. Paul, and K. Nakanishi. (1999) IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 96:13962–13966.PubMedGoogle Scholar
  17. 17.
    Grabbe, S., and T. Schwarz. (1998) Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19:37–44.PubMedGoogle Scholar
  18. 18.
    Takeshita, K., T. Yamasaki, S. Akira, F. Gantner, and K. B. Bacon. (2004) Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol 16:685–695.PubMedGoogle Scholar
  19. 19.
    Yokozeki, H., M. Ghoreishi, S. Takagawa, K. Takayama, T. Satoh, I. Katayama, K. Takeda, S. Akira, and K. Nishioka. (2000) Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med 191:995–1004.PubMedGoogle Scholar
  20. 20.
    Askenase, P. W., M. Szczepanik, A. Itakura, C. Kiener, and R. A. Campos. (2004) Extravascular T-cell recruitment requires initiation begun by Valpha14+ NKT cells and B-1 B cells. Trends Immunol 25:441–449.PubMedGoogle Scholar
  21. 21.
    Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. (2005) Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749–786.PubMedGoogle Scholar
  22. 22.
    Jawdat, D. M., G. Rowden, and J. S. Marshall. (2006) Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol 177:1755–1762.PubMedGoogle Scholar
  23. 23.
    Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. (1996) Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184:1397–1411.PubMedGoogle Scholar
  24. 24.
    Hwang, J. M., J. Yamanouchi, P. Santamaria, and P. Kubes. (2004) A critical temporal window for selectin-dependent CD4+ lymphocyte homing and initiation of late-phase inflammation in contact sensitivity. J Exp Med 199:1223–1234.PubMedGoogle Scholar
  25. 25.
    Van Loveren, H., K. Kato, R. Meade, D. R. Green, M. Horowitz, W. Ptak, and P. W. Askenase. (1984) Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity. J Immunol 133:2402–2411.PubMedGoogle Scholar
  26. 26.
    van Loveren, H., R. Meade, and P. W. Askenase. (1983) An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J Exp Med 157:1604–1617.PubMedGoogle Scholar
  27. 27.
    Norman, M. U., J. Hwang, S. Hulliger, C. S. Bonder, J. Yamanouchi, P. Santamaria, and P. Kubes. (2008) Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response. Am J Pathol 172:1638–1649.PubMedGoogle Scholar
  28. 28.
    Biedermann, T., M. Kneilling, R. Mailhammer, K. Maier, C. A. Sander, G. Kollias, S. L. Kunkel, L. Hultner, and M. Rocken. (2000) Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 192:1441–1452.PubMedGoogle Scholar
  29. 29.
    Gordon, J. R., and S. J. Galli. (1990) Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 346:274–276.PubMedGoogle Scholar
  30. 30.
    Gordon, J. R., and S. J. Galli. (1991) Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med 174:103–107.PubMedGoogle Scholar
  31. 31.
    Bryce, P. J., M. L. Miller, I. Miyajima, M. Tsai, S. J. Galli, and H. C. Oettgen. (2004) Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20:381–392.PubMedGoogle Scholar
  32. 32.
    Jawdat, D. M., E. J. Albert, G. Rowden, I. D. Haidl, and J. S. Marshall. (2004) IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 173: 5275–5282.PubMedGoogle Scholar
  33. 33.
    Suto, H., S. Nakae, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. (2006) Mast cell-associated TNF promotes dendritic cell migration. J Immunol 176:4102–4112.PubMedGoogle Scholar
  34. 34.
    Roelandt, T., C. Heughebaert, and J. P. Hachem. (2008) Proteolytically active allergens cause barrier breakdown. J Invest Dermatol 128:1878–1880.PubMedGoogle Scholar
  35. 35.
    Schittek, B., M. Paulmann, I. Senyurek, and H. Steffen. (2008) The role of antimicrobial peptides in human skin and in skin infectious diseases. Infect Disord Drug Targets 8: 135–143.PubMedGoogle Scholar
  36. 36.
    Schmid-Wendtner, M. H., and H. C. Korting. (2006) The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 19:296–302.PubMedGoogle Scholar
  37. 37.
    Nilsson, G., M. Johnell, C. H. Hammer, H. L. Tiffany, K. Nilsson, D. D. Metcalfe, A. Siegbahn, and P. M. Murphy. (1996) C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157:1693–1698.PubMedGoogle Scholar
  38. 38.
    Heib, V., M. Becker, T. Warger, G. Rechtsteiner, C. Tertilt, M. Klein, T. Bopp, C. Taube, H. Schild, E. Schmitt, and M. Stassen. (2007) Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood 110:946–953.PubMedGoogle Scholar
  39. 39.
    McCurdy, J. D., T. J. Lin, and J. S. Marshall. (2001) Toll-like receptor 4-mediated activation of murine mast cells. J Leukoc Biol 70:977–984.PubMedGoogle Scholar
  40. 40.
    Supajatura, V., H. Ushio, A. Nakao, K. Okumura, C. Ra, and H. Ogawa. (2001) Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J Immunol 167:2250–2256.PubMedGoogle Scholar
  41. 41.
    Varadaradjalou, S., F. Feger, N. Thieblemont, N. B. Hamouda, J. M. Pleau, M. Dy, and M. Arock. (2003) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol 33:899–906.PubMedGoogle Scholar
  42. 42.
    Liu, Y. J. (2006) Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 203:269–273.PubMedGoogle Scholar
  43. 43.
    Ziegler, S. F., and Y. J. Liu. (2006) Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 7:709–714.PubMedGoogle Scholar
  44. 44.
    Miyata, M., K. Hatsushika, T. Ando, N. Shimokawa, Y. Ohnuma, R. Katoh, H. Suto, H. Ogawa, K. Masuyama, and A. Nakao. (2008) Mast cell regulation of epithelial TSLP expression plays an important role in the development of allergic rhinitis. Eur J Immunol 38:1487–1492.PubMedGoogle Scholar
  45. 45.
    Mazzoni, A., R. P. Siraganian, C. A. Leifer, and D. M. Segal. (2006) Dendritic cell modulation by mast cells controls the Th1/Th2 balance in responding T cells. J Immunol 177: 3577–3581.PubMedGoogle Scholar
  46. 46.
    McIlroy, A., G. Caron, S. Blanchard, I. Fremaux, D. Duluc, Y. Delneste, A. Chevailler, and P. Jeannin. (2006) Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-gamma-induced CXCL10 production by immature human dendritic cells. Immunology 117:507–516.PubMedGoogle Scholar
  47. 47.
    Theiner, G., A. Gessner, and M. B. Lutz. (2006) The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo. Immunobiology 211:463–472.PubMedGoogle Scholar
  48. 48.
    Galli, S. J., S. Nakae, and M. Tsai. (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6:135–142.PubMedGoogle Scholar
  49. 49.
    Galli, S. J., M. Grimbaldeston, and M. Tsai. (2008) Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8:478–486.PubMedGoogle Scholar
  50. 50.
    Metz, M., M. A. Grimbaldeston, S. Nakae, A. M. Piliponsky, M. Tsai, and S. J. Galli. (2007) Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 217: 304–328.PubMedGoogle Scholar
  51. 51.
    Sayed, B. A., and M. A. Brown. (2007) Mast cells as modulators of T-cell responses. Immunol Rev 217:53–64.PubMedGoogle Scholar
  52. 52.
    Stelekati, E., Z. Orinska, and S. Bulfone-Paus. (2007) Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 212:505–519.PubMedGoogle Scholar
  53. 53.
    Mekori, Y. A. (2004) The mastocyte: the “other” inflammatory cell in immunopathogenesis. J Allergy Clin Immunol 114:52–57.PubMedGoogle Scholar
  54. 54.
    Tanzola, M. B., M. Robbie-Ryan, C. A. Gutekunst, and M. A. Brown. (2003) Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J Immunol 171:4385–4391.PubMedGoogle Scholar
  55. 55.
    Wang, H. W., N. Tedla, A. R. Lloyd, D. Wakefield, and P. H. McNeil. (1998) Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 102:1617–1626.PubMedGoogle Scholar
  56. 56.
    Frandji, P., C. Oskeritzian, F. Cacaraci, J. Lapeyre, R. Peronet, B. David, J. G. Guillet, and S. Mecheri. (1993) Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 151:6318–6328.PubMedGoogle Scholar
  57. 57.
    Koch, N., and A. W. Harris. (1984) Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development. J Immunol 132:12–15.PubMedGoogle Scholar
  58. 58.
    Malaviya, R., N. J. Twesten, E. A. Ross, S. N. Abraham, and J. D. Pfeifer. (1996) Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156:1490–1496.PubMedGoogle Scholar
  59. 59.
    Wong, G. H., I. Clark-Lewis, J. L. McKimm-Breschkin, and J. W. Schrader. (1982) Interferon-gamma-like molecule induces Ia antigens on cultured mast cell progenitors. Proc Natl Acad Sci USA 79:6989–6993.PubMedGoogle Scholar
  60. 60.
    Frandji, P., C. Tkaczyk, C. Oskeritzian, B. David, C. Desaymard, and S. Mecheri. (1996) Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur J Immunol 26:2517–2528.PubMedGoogle Scholar
  61. 61.
    Nakae, S., H. Suto, M. Iikura, M. Kakurai, J. D. Sedgwick, M. Tsai, and S. J. Galli. (2006) Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176:2238–2248.PubMedGoogle Scholar
  62. 62.
    Frandji, P., C. Tkaczyk, C. Oskeritzian, J. Lapeyre, R. Peronet, B. David, J. G. Guillet, and S. Mecheri. (1995) Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma. Cell Immunol 163:37–46.PubMedGoogle Scholar
  63. 63.
    Walsh, L. J. (1995) Ultraviolet B irradiation of skin induces mast cell degranulation and release of tumor necrosis factor-alpha. Immunol Cell Biol 73:226–233.PubMedGoogle Scholar
  64. 64.
    Meng, H., M. J. Marchese, J. A. Garlick, A. Jelaska, J. H. Korn, J. Gailit, R. A. Clark, and B. L. Gruber. (1995) Mast cells induce T-cell adhesion to human fibroblasts by regulating intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression. J Invest Dermatol 105:789–796.PubMedGoogle Scholar
  65. 65.
    McLachlan, J. B., J. P. Hart, S. V. Pizzo, C. P. Shelburne, H. F. Staats, M. D. Gunn, and S. N. Abraham. (2003) Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 4:1199–1205.PubMedGoogle Scholar
  66. 66.
    Zhuang, X., A. J. Silverman, and R. Silver. (1996) Brain mast cell degranulation regulates blood-brain barrier. J Neurobiol 31:393–403.PubMedGoogle Scholar
  67. 67.
    Marshall, J. S., C. A. King, and J. D. McCurdy. (2003) Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr Pharm Des 9:11–24.PubMedGoogle Scholar
  68. 68.
    Mekori, Y. A., and D. D. Metcalfe. (1999) Mast cell-T cell interactions. J Allergy Clin Immunol 104:517–523.PubMedGoogle Scholar
  69. 69.
    Jutel, M., T. Watanabe, S. Klunker, M. Akdis, O. A. Thomet, J. Malolepszy, T. Zak-Nejmark, R. Koga, T. Kobayashi, K. Blaser, and C. A. Akdis. (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413:420–425.PubMedGoogle Scholar
  70. 70.
    Holgate, S. T. (2008) Pathogenesis of asthma. Clin Exp Allergy 38:872–897.PubMedGoogle Scholar
  71. 71.
    Cairns, J. A., and A. F. Walls. (1996) Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 156:275–283.PubMedGoogle Scholar
  72. 72.
    Compton, S. J., J. A. Cairns, S. T. Holgate, and A. F. Walls. (1998) The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: tryptase induces expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 161: 1939–1946.PubMedGoogle Scholar
  73. 73.
    Berger, P., D. W. Perng, H. Thabrew, S. J. Compton, J. A. Cairns, A. R. McEuen, R. Marthan, J. M. Tunon De Lara, and A. F. Walls. (2001) Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J Appl Physiol 91:1372–1379.PubMedGoogle Scholar
  74. 74.
    Okumura, S., H. Sagara, T. Fukuda, H. Saito, and Y. Okayama. (2005) FcepsilonRI-mediated amphiregulin production by human mast cells increases mucin gene expression in epithelial cells. J Allergy Clin Immunol 115:272–279.PubMedGoogle Scholar
  75. 75.
    Wang, S. W., C. K. Oh, S. H. Cho, G. Hu, R. Martin, S. Demissie-Sanders, K. Li, M. Moyle, and Z. Yao. (2005) Amphiregulin expression in human mast cells and its effect on the primary human lung fibroblasts. J Allergy Clin Immunol 115:287–294.PubMedGoogle Scholar
  76. 76.
    Woodman, L., S. Siddiqui, G. Cruse, A. Sutcliffe, R. Saunders, D. Kaur, P. Bradding, and C. Brightling. (2008) Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta 1. J Immunol 181:5001–5007.PubMedGoogle Scholar
  77. 77.
    Black, P. N., R. W. Fuller, G. W. Taylor, P. J. Barnes, and C. T. Dollery. (1989) Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects. Thorax 44:491–495.PubMedGoogle Scholar
  78. 78.
    Rajah, R., S. E. Nunn, D. J. Herrick, M. M. Grunstein, and P. Cohen. (1996) Leukotriene D4 induces MMP-1, which functions as an IGFBP protease in human airway smooth muscle cells. Am J Physiol 271:L1014–1022.PubMedGoogle Scholar
  79. 79.
    Dunnill, M. S. (1960) The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol 13:27–33.PubMedGoogle Scholar
  80. 80.
    Li, X., and J. W. Wilson. (1997) Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 156:229–233.PubMedGoogle Scholar
  81. 81.
    Orsida, B. E., X. Li, B. Hickey, F. Thien, J. W. Wilson, and E. H. Walters. (1999) Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 54:289–295.PubMedGoogle Scholar
  82. 82.
    Redington, A. E., W. R. Roche, J. Madden, A. J. Frew, R. Djukanovic, S. T. Holgate, and P. H. Howarth. (2001) Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 107:384–387.PubMedGoogle Scholar
  83. 83.
    Horiuchi, T., and P. F. Weller. (1997) Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 17:70–77.PubMedGoogle Scholar
  84. 84.
    Richter, A., S. M. Puddicombe, J. L. Lordan, F. Bucchieri, S. J. Wilson, R. Djukanovic, G. Dent, S. T. Holgate, and D. E. Davies. (2001) The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 25:385–391.PubMedGoogle Scholar
  85. 85.
    Lee, C. G., H. Link, P. Baluk, R. J. Homer, S. Chapoval, V. Bhandari, M. J. Kang, L. Cohn, Y. K. Kim, D. M. McDonald, and J. A. Elias. (2004) Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 10:1095–1103.PubMedGoogle Scholar
  86. 86.
    Puxeddu, I., D. Ribatti, E. Crivellato, and F. Levi-Schaffer. (2005) Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J Allergy Clin Immunol 116:531–536.PubMedGoogle Scholar
  87. 87.
    Amini, R. M., K. Aaltonen, H. Nevanlinna, R. Carvalho, L. Salonen, P. Heikkila, and C. Blomqvist. (2007) Mast cells and eosinophils in invasive breast carcinoma. BMC Cancer 7:165.PubMedGoogle Scholar
  88. 88.
    Lachter, J., M. Stein, C. Lichtig, S. Eidelman, and M. Munichor. (1995) Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum 38:290–293.PubMedGoogle Scholar
  89. 89.
    Sivridis, E., A. Giatromanolaki, and M. I. Koukourakis. (2003) The vascular network of tumours – what is it not for? J Pathol 201:173–180.PubMedGoogle Scholar
  90. 90.
    Goldmann, E. (1908) The growth of malignant disease in man and the lower animals, with special reference to the Vascular system. Proc R Soc Med 1:1–13.PubMedGoogle Scholar
  91. 91.
    Starkey, J. R., P. K. Crowle, and S. Taubenberger. (1988) Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 42:48–52.PubMedGoogle Scholar
  92. 92.
    Coussens, L. M., W. W. Raymond, G. Bergers, M. Laig-Webster, O. Behrendtsen, Z. Werb, G. H. Caughey, and D. Hanahan. (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382–1397.PubMedGoogle Scholar
  93. 93.
    Gounaris, E., S. E. Erdman, C. Restaino, M. F. Gurish, D. S. Friend, F. Gounari, D. M. Lee, G. Zhang, J. N. Glickman, K. Shin, V. P. Rao, T. Poutahidis, R. Weissleder, K. M. McNagny, and K. Khazaie. (2007) Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci USA 104:19977–19982.PubMedGoogle Scholar
  94. 94.
    Soucek, L., E. R. Lawlor, D. Soto, K. Shchors, L. B. Swigart, and G. I. Evan. (2007) Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13:1211–1218.PubMedGoogle Scholar
  95. 95.
    Conti, P., X. Pang, W. Boucher, R. Letourneau, M. Reale, R. C. Barbacane, J. Thibault, and T. C. Theoharides. (1997) Impact of Rantes and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89:4120–4127.PubMedGoogle Scholar
  96. 96.
    Conti, P., M. Reale, R. C. Barbacane, R. Letourneau, and T. C. Theoharides. (1998) Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell-deficient W/WV mice. FASEB J 12:1693–1700.PubMedGoogle Scholar
  97. 97.
    Crivellato, E., B. Nico, and D. Ribatti. (2008) Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett 269:1–6.PubMedGoogle Scholar
  98. 98.
    Brew, R., J. S. Erikson, D. C. West, A. R. Kinsella, J. Slavin, and S. E. Christmas. (2000) Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 12:78–85.PubMedGoogle Scholar
  99. 99.
    Salven, P., K. Hattori, B. Heissig, and S. Rafii. (2002) Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB J 16:1471–1473.PubMedGoogle Scholar
  100. 100.
    Hong, D. S., L. S. Angelo, and R. Kurzrock. (2007) Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110:1911–1928.PubMedGoogle Scholar
  101. 101.
    Almholt, K., and M. Johnsen. (2003) Stromal cell involvement in cancer. Recent Results Cancer Res 162:31–42.PubMedGoogle Scholar
  102. 102.
    Esposito, P., N. Chandler, K. Kandere, S. Basu, S. Jacobson, R. Connolly, D. Tutor, and T. C. Theoharides. (2002) Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J Pharmacol Exp Ther 303: 1061–1066.PubMedGoogle Scholar
  103. 103.
    Ch’ng, S., R. A.Wallis, L. Yuan, F. P. Davis, and S. T. Tan. (2006) Mast cells and cutaneous malignancies. Mod Pathol 19:149–159.PubMedGoogle Scholar
  104. 104.
    Beil, W. J., W. Fureder, H. Wiener, K. Grossschmidt, U. Maier, A. Schedle, H. C. Bankl, K. Lechner, and P. Valent. (1998) Phenotypic and functional characterization of mast cells derived from renal tumor tissues. Exp Hematol 26:158–169.PubMedGoogle Scholar
  105. 105.
    Wooley, D., and Norrby K. (1993) Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumor tissue. Adv Biosci 89:71–115.Google Scholar
  106. 106.
    Ribatti, D., E. Crivellato, A. M. Roccaro, R. Ria, and A. Vacca. (2004) Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy 34:1660–1664.PubMedGoogle Scholar
  107. 107.
    Molin, D., A. Edstrom, I. Glimelius, B. Glimelius, G. Nilsson, C. Sundstrom, and G. Enblad. (2002) Mast cell infiltration correlates with poor prognosis in Hodgkin’s lymphoma. Br J Haematol 119:122–124.PubMedGoogle Scholar
  108. 108.
    Costa, J. J., G. D. Demetri, T. J. Harrist, A. M. Dvorak, D. F. Hayes, E. A. Merica, D. M. Menchaca, A. J. Gringeri, L. B. Schwartz, and S. J. Galli. (1996) Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681–2686.PubMedGoogle Scholar
  109. 109.
    Coussens, L. M., and Z. Werb. (2002) Inflammation and cancer. Nature 420:860–867.PubMedGoogle Scholar
  110. 110.
    Sinnamon, M. J., K. J. Carter, L. P. Sims, B. Lafleur, B. Fingleton, and L. M. Matrisian. (2008) A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 29: 880–886.PubMedGoogle Scholar
  111. 111.
    Gooch, J. L., A. V. Lee, and D. Yee. (1998) Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res 58:4199–4205.PubMedGoogle Scholar
  112. 112.
    Theoharides, T. C., and P. Conti. (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25:235–241.PubMedGoogle Scholar
  113. 113.
    Wedemeyer, J., and S. J. Galli. (2005) Decreased susceptibility of mast cell-deficient Kit(W)/Kit(W-v) mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors. Lab Invest 85:388–396.PubMedGoogle Scholar
  114. 114.
    Cuenca, A., F. Cheng, and H. Wang. (2003) Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. Cancer Res 63:9007–9015.PubMedGoogle Scholar
  115. 115.
    Gajewski, T. F., Y. Meng, C. Blank, I. Brown, A. Kacha, J. Kline, and H. Harlin. (2006) Immune resistance orchestrated by the tumor microenvironment. Immunol Rev 213: 131–145.PubMedGoogle Scholar
  116. 116.
    Ochsenbein, A. F., P. Klenerman, U. Karrer, B. Ludewig, M. Pericin, H. Hengartner, and R. M. Zinkernagel. (1999) Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci USA 96:2233–2238.PubMedGoogle Scholar
  117. 117.
    Sotomayor, E. M., I. Borrello, D. M. Rattis, A. G. Cuena, J. Abrams, K. Staveley-O’Carroll, and H. I. Levitsky. (2001) Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression. Blood 98:1070–1077.PubMedGoogle Scholar
  118. 118.
    Zou, W. (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 6:295–307.PubMedGoogle Scholar
  119. 119.
    Theoharides, T. C., D. Kempuraj, M. Tagen, P. Conti, and D. Kalogeromitros. (2007) Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 217:65–78.PubMedGoogle Scholar
  120. 120.
    Pos, Z., Z. Wiener, P. Pocza, M. Racz, S. Toth, Z. Darvas, V. Molnar, H. Hegyesi, and A. Falus. (2008) Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma. Cancer Res 68:1997–2005.PubMedGoogle Scholar
  121. 121.
    Cianchi, F., M. C. Vinci, and E. Masini. (2008) Histamine in cancer: the dual faces of the coin. Cancer Biol Ther 7:36–37.PubMedGoogle Scholar
  122. 122.
    Hart, P. H., M. A. Grimbaldeston, G. J. Swift, A. Jaksic, F. P. Noonan, and J. J. Finlay-Jones. (1998) Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 187: 2045–2053.PubMedGoogle Scholar
  123. 123.
    Depinay, N., F. Hacini, W. Beghdadi, R. Peronet, and S. Mecheri. (2006) Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J Immunol 176:4141–4146.PubMedGoogle Scholar
  124. 124.
    Aune, T. M., H. W. Golden, K. M. McGrath. (1994) Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol 153:489–498.PubMedGoogle Scholar
  125. 125.
    Laberge, S., W. W. Cruikshank, D. J. Beer, and D. M. Center. (1996) Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+ T cells in vitro. J Immunol 156:310–315.PubMedGoogle Scholar
  126. 126.
    León-Ponte, M., G. P. Ahern, and P. J. O’Connell. (2007) Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 109:3139–3146.PubMedGoogle Scholar
  127. 127.
    Keir, M. E., M. J. Butte, G. J. Freeman, and A. H. Sharpe. (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677–704.Google Scholar
  128. 128.
    Lu, L. F., E. F. Lind, D. C. Gondek, K. A. Bennett, M. W. Gleeson, K. Pino-Lagos, Z. A. Scott, A. J. Coyle, J. L. Reed, J. Van Snick, T. B. Strom, X. X. Zheng, and R. J. Noelle. (2006) Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997–1002.PubMedGoogle Scholar
  129. 129.
    Samoszuk, M., and M. A. Corwin. (2003) Acceleration of tumor growth and peri-tumoral blood clotting by imatinib mesylate (Gleevec). Int J Cancer 106:647–652.Google Scholar
  130. 130.
    Ribatti, D., A. Vacca, B. Nico, F. Quondamatteo, R. Ria, M. Minischetti, A. Marzullo, R. Herken, L. Roncali, and F. Dammacco. (1999) Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 79:451–455.Google Scholar
  131. 131.
    Fisher, E. R., S. M. Paik, H. Rockette, J. Jones, R. Caplan, and B. Fisher. (1989) Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01). Hum Pathol 20:159–163.Google Scholar
  132. 132.
    Ribatti, D., M. G. Ennas, A. Vacca, F. Ferreli, B. Nico, S. Orru, and P. Sirigu. (2003) Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 33:420–425.Google Scholar
  133. 133.
    Iamaroon, A., S. Pongsiriwet, S. Jittidecharaks, K. Pattanaporn, S. Prapayasatok, and S. Wanachantararak. (2003) Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med 32:195–199.Google Scholar
  134. 134.
    Imada, A., N. Shijubo, H. Kojima, and S. Abe. (2000) Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 15:1087–1093.Google Scholar
  135. 135.
    Ribatti, D., B. Nico, C. Maxia, V. Longo, D. Murtas, D. Mangieri, M. T. Perra, M. De Giorgis, F. Piras, E. Crivellato, and P. Sirigu. (2007) Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium. J Cell Mol Med 11:585–589.Google Scholar
  136. 136.
    Samoszuk, M., E. Kanakubo, and J. K. Chan. (2005) Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer 15:121.Google Scholar
  137. 137.
    Aaltomaa, S., P. Lipponen, S. Papinaho, and V. M. Kosma. (1993) Mast cells in breast cancer. Anticancer Res 13:785–788.Google Scholar
  138. 138.
    Dabiri, S., D. Huntsman, N. Makretsov, M. Cheang, B. Gilks, C. Bajdik, K. Gelmon, S. Chia, and M. Hayes. (2004) The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis. Mod Pathol 17:690–695.Google Scholar
  139. 139.
    Chan, J. K., A. Magistris, V. Loizzi, F. Lin, J. Rutgers, K. Osann, P. J. DiSaia, and M. Samoszuk. (2005) Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Gynecol Oncol 99:20–25.Google Scholar
  140. 140.
    Tuna, B., K. Yorukoglu, M. Unlu, M. U. Mungan, and Z. Kirkali. (2006) Association of mast cells with microvessel density in renal cell carcinomas. Eur Urol 50:530–534.Google Scholar
  141. 141.
    Fisher, E. R., R. Sass, G. Watkins, J. Johal, and B. Fisher. (1985) Tissue mast cells in breast cancer. Breast Cancer Res Treat 5:285–291.Google Scholar
  142. 142.
    Welsh, T. J., R. H. Green, D. Richardson, D. A. Waller, K. J. O’Byrne, and P. Bradding. (2005) Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23:8959–8967.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Anna Wasiuk
    • 1
  • Victor C. de Vries
    • 1
  • Elizabeth C. Nowak
    • 1
  • Randolph J. Noelle
    • 1
    Email author
  1. 1.Department of Microbiology and ImmunologyDartmouth Medical SchoolLebanonUSA

Personalised recommendations